Drug Trial Radar · NCT02598596
Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect
Last checked: Nov 20, 2026Latest source record: Oct 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
132
Actual
Start
Dec 2015
Primary completion
Apr 13, 2020
Study completion Apr 27, 2020
Sponsor
- Lead sponsor
- Ampel BioSolutions, LLCIndustry
- Sponsor type
- Industry
- Collaborators
- IND 2 Results LLC
- First posted
- Nov 6, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effect of a high zone tolerizing regimen of pegloticase on clinical outcome, as defined by an serum uric acid level \<6 mg/dL, in patients with chronic, refractory gout.
Conditions
- Gout
Interventions
PegloticaseBiological
Pegloticase, IV
AzathioprineDrug
Azathioprine (1.25 mg/kg, followed by 2.5 mg/kg) oral, daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Normalization of serum uric acid (SUA) in subjects receiving a tolerizing regimen of pegloticaseTime frame: Week 17
- Normalization of serum uric acid (SUA) in subjects receiving pegloticase and azathioprine (AZA) immunosuppressive therapyTime frame: Week 25
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birminingham
Birmingham, Alabama
Rheumatology Associates of North Alabama
Huntsville, Alabama
The Center for Rheumatology and Bone Research
Wheaton, Maryland
Clinical Pharmacology Study Group
Worcester, Massachusetts
Henry Ford Health System
Detroit, Michigan
Saint Paul Rheumatology
Eagan, Minnesota
Buffalo Rheumatology and Medicine
Orchard Park, New York
Montefiore Medical Center
The Bronx, New York
Cleveland Clinic
Cleveland, Ohio
Altoona Center for Clinical Research
Duncansville, Pennsylvania
ACME Research, LLC
Orangeburg, South Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.